Clinuvel Pharmaceuticals

What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Fibonacci Retracements

Score

0.7

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 10 44.5 0.50% 1.00% 36.1% -6.3% 149.0%
SHORT 11 25.5 0.27% 0.38% 10.1% -5.0% -9.7%

Summary

Technical Analysis

Clinuvel Pharmaceuticals (CUV.AX)


Indicator:

FIBONACCI RETRACTION


Signal Strength: MEDIUM
Recommendation:

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading position.


Clinuvel Pharmaceuticals (ASX:CUV) : The current Fibonacci Retraction levels are:
(23.61%) $27.03
(38.2%) $27.98
(50%) $28.75
(61.8%) $29.52

The current support levels are:
(78.6%) $30.61
(100%) $32
(138.2%) $34.48
(161.8%) $36.02
(261.8%) $42.52
(423.61%) $53.03



A Fibonacci retracement is a term used in technical analysis that refers to areas of support (price stops going lower) or resistance (price stops going higher). Fibonacci retracement levels use horizontal lines to indicate areas of support or resistance at the key Fibonacci levels before the trend continues in the original direction.

Calculation: Fibonacci Retracements:
1) Uptrend: C = B — (B — A) x N%;
2) Downtrend: C = B + (A — B) x N%;
3) Fibonacci Levels:
a) 23.61%;
b) 38.2%;
c) 50%;
d) 61.8%;
e) 78.6%;
f) 100%,


PROFILE: Clinuvel Pharmaceuticals (CUV.AX)


Stock Exchange: ASX
Company: Clinuvel Pharmaceuticals
Ticker Codes: | CUV.AX | ASX:CUV |

About Clinuvel Pharmaceuticals (ASX:CUV):

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of a range of severe skin disorders. Its lead drug compound is SCENESSE, a medicinal photoprotective and repigmentation drug that has completed Phase II and III trials in the United States and Europe, which is used for the prevention of phototoxicity in adults with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue that acts as a potent skin protectant; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. It has operations in Europe, the United States, and Singapore. The company is headquartered in Melbourne, Australia.

Top 10:

Fibonacci Retracements

Download
Company Close Change(%) Volume Value Signal
PNV Polynovo 1.94 11.8 11,074,353 0.07 BULLISH
LYC Lynas Corporation 2.58 8.9 9,724,310 0.9 BULLISH
ISD Isentia 0.26 8.3 518,734 0.2 BULLISH
MLX Metals X 0.11 8.2 3,754,499 0.12 BULLISH
IMF IMF 3.81 6.7 2,751,384 0.46 BULLISH
BSL Bluescope Steel 15.21 5.2 2,787,185 2.17 BULLISH
LNK Link 5.87 5 3,785,284 0.7 BULLISH
RWC Reliance Worldwide Corporation 4.18 4.8 2,029,284 0.67 BULLISH
MND Monadelphous 17.47 4.5 518,378 4.24 BULLISH
PPH Pan Pharmaceuticals 3.93 4.5 41,736 0.46 BULLISH